v-Abl signaling disrupts SOCS-1 function in transformed pre-B cells

Molecular Cell

Volumn 15, Issue 3, 2004, Pages 329-341

  Limnander, André ^a   Danial, Nika N ^a   Rothman, Paul B ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; IMATINIB; JANUS KINASE; PHOSPHOTRANSFERASE INHIBITOR; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; GENE EXPRESSION; MOUSE; NONHUMAN; ONCOGENE; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; CARRIER PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MUTATION; ONCOGENE PROTEINS V-ABL; PROTEIN-TYROSINE KINASES; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

ANIMALIA; JANUS;

EID: 4143137593     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2004.06.041     Document Type: Article

References (47)

1. Alexander W.S., Starr R., Fenner J.E., Scott C.L., Handman E., Sprigg N.S., Corbin J.E., Cornish A.L., Darwiche R., Owczarek C.M., et al. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell. 98:1999;597-608
2. Chaturvedi P., Sharma S., Reddy E.P. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs. Mol. Cell. Biol. 17:1997;3295-3304
3. Chen X.P., Losman J.A., Rothman P. SOCS proteins, regulators of intracellular signaling. Immunity. 13:2000;287-290
4. Chen X.P., Losman J.A., Cowan S., Donahue E., Fay S., Vuong B.Q., Nawijn M.C., Capece D., Cohan V.L., Rothman P. Pim serine/threonine kinases regulate the stability of Socs-1 protein. Proc. Natl. Acad. Sci. USA. 99:2002;2175-2180
5. Danial N.N., Rothman P. JAK-STAT signaling activated by Abl oncogenes. Oncogene. 19:2000;2523-2531
6. Danial N.N., Pernis A., Rothman P.B. Jak-STAT signaling induced by the v-abl oncogene. Science. 269:1995;1875-1877
7. Danial N.N., Losman J.A., Lu T., Yip N., Krishnan K., Krolewski J., Goff S.P., Wang J.Y., Rothman P.B. Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation. Mol. Cell. Biol. 18:1998;6795-6804
8. De Sepulveda P., Ilangumaran S., Rottapel R. Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation. J. Biol. Chem. 275:2000;14005-14008
9. Endo T.A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 387:1997;921-924
10. Engelman A., Rosenberg N. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity. J. Virol. 64:1990;4242-4251
11. Frantsve J., Schwaller J., Sternberg D.W., Kutok J., Gilliland D.G. Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol. Cell. Biol. 21:2001;3547-3557
12. Galm O., Yoshikawa H., Esteller M., Osieka R., Herman J.G. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood. 101:2003;2784-2788
13. Haan S., Ferguson P., Sommer U., Hiremath M., McVicar D.W., Heinrich P.C., Johnston J.A., Cacalano N.A. Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation. J. Biol. Chem. 278:2003;31972-31979
14. Hilbert D.M., Theisen P.W., Rudikoff E.K., Bauer S.R. Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice. Oncogene. 17:1998;2125-2135
15. Hilton D.J., Richardson R.T., Alexander W.S., Viney E.M., Willson T.A., Sprigg N.S., Starr R., Nicholson S.E., Metcalf D., Nicola N.A. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA. 95:1998;114-119
16. Hock H., Dorsch M., Diamantstein T., Blankenstein T. Interleukin 7 induces CD4+ T cell-dependent tumor rejection. J. Exp. Med. 174:1991;1291-1298
17. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., Kaelin W.G. Jr. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation. implications for O2 sensing Science. 292:2001;464-468
18. Iwamoto T., Senga T., Naito Y., Matsuda S., Miyake Y., Yoshimura A., Hamaguchi M. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation. Oncogene. 19:2000;4795-4801
19. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A., Hebestreit H.F., Mukherji M., Schofield C.J., et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 292:2001;468-472
20. Kamizono S., Hanada T., Yasukawa H., Minoguchi S., Kato R., Minoguchi M., Hattori K., Hatakeyama S., Yada M., Morita S., et al. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J. Biol. Chem. 276:2001;12530-12538
21. Kamura T., Sato S., Haque D., Liu L., Kaelin W.G. Jr., Conaway R.C., Conaway J.W. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12:1998;3872-3881
22. Kile B.T., Schulman B.A., Alexander W.S., Nicola N.A., Martin H.M., Hilton D.J. The SOCS box. a tale of destruction and degradation Trends Biochem. Sci. 27:2002;235-241
23. Klejman A., Schreiner S.J., Nieborowska-Skorska M., Slupianek A., Wilson M., Smithgall T.E., Skorski T. The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells. EMBO J. 21:2002;5766-5774
24. Losman J.A., Chen X.P., Vuong B.Q., Fay S., Rothman P.B. Protein phosphatase 2A regulates the stability of Pim protein kinases. J. Biol. Chem. 278:2003;4800-4805
25. Marine J.C., Topham D.J., McKay C., Wang D., Parganas E., Stravopodis D., Yoshimura A., Ihle J.N. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell. 98:1999;609-616
26. Monni R., Santos S.C., Mauchauffe M., Berger R., Ghysdael J., Gouilleux F., Gisselbrecht S., Bernard O., Penard-Lacronique V. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells. Oncogene. 20:2001;849-858
27. Nagai H., Kim Y.S., Konishi N., Baba M., Kubota T., Yoshimura A., Emi M. Combined hypermethylation and chromosome loss associated with inactivation of SSI-1/SOCS-1/JAB gene in human hepatocellular carcinomas. Cancer Lett. 186:2002;59-65
28. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., et al. Structure and function of a new STAT-induced STAT inhibitor. Nature. 387:1997;924-929
29. Nicholson S.E., Willson T.A., Farley A., Starr R., Zhang J.G., Baca M., Alexander W.S., Metcalf D., Hilton D.J., Nicola N.A. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J. 18:1999;375-385
30. Nieborowska-Skorska M., Hoser G., Kossev P., Wasik M.A., Skorski T. Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis. Blood. 99:2002;4531-4539
31. Oki S., Limnander A., Danial N.N., Rothman P.B. Functional involvement of Akt signaling downstream of Jak1 in v-Abl-induced activation of hematopoietic cells. Blood. 100:2002;966-973
32. Raffel G.D., Parmar K., Rosenberg N. In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction. J. Biol. Chem. 271:1996;4640-4645
33. Rodig S.J., Meraz M.A., White J.M., Lampe P.A., Riley J.K., Arthur C.D., King K.L., Sheehan K.C., Yin L., Pennica D., et al. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell. 93:1998;373-383
34. Rosenberg N. Abl-mediated transformation, immunoglobulin gene rearrangements and arrest of B lymphocyte differentiation. Semin. Cancer Biol. 5:1994;95-102
35. Rottapel R., Ilangumaran S., Neale C., La Rose J., Ho J.M., Nguyen M.H., Barber D., Dubreuil P., de Sepulveda P. The tumor suppressor activity of SOCS-1. Oncogene. 21:2002;4351-4362
36. Schindler T., Bornmann W., Pellicena P., Miller W.T., Clarkson B., Kuriyan J. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science. 289:2000;1938-1942
37. Sexl V., Kovacic B., Piekorz R., Moriggl R., Stoiber D., Hoffmeyer A., Liebminger R., Kudlacek O., Weisz E., Rothammer K., Ihle J.N. Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation. Blood. 101:2003;4937-4943
38. Shore S.K., Tantravahi R.V., Reddy E.P. Transforming pathways activated by the v-Abl tyrosine kinase. Oncogene. 21:2002;8568-8576
39. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., Hilton D.J. A family of cytokine-inducible inhibitors of signalling. Nature. 387:1997;917-921
40. Stebbins C.E., Kaelin W.G. Jr., Pavletich N.P. Structure of the VHL-ElonginC-ElonginB complex. implications for VHL tumor suppressor function Science. 284:1999;455-461
41. Unnikrishnan I., Radfar A., Jenab-Wolcott J., Rosenberg N. p53 mediates apoptotic crisis in primary Abelson virus-transformed pre-B cells. Mol. Cell. Biol. 19:1999;4825-4831
42. Warren D., Heilpern A.J., Berg K., Rosenberg N. The carboxyl terminus of v-Abl protein can augment SH2 domain function. J. Virol. 74:2000;4495-4504
43. Witte O. The role of Bcr-Abl in chronic myeloid leukemia and stem cell biology. Semin. Hematol. 38:2001;3-8
44. Yasukawa H., Misawa H., Sakamoto H., Masuhara M., Sasaki A., Wakioka T., Ohtsuka S., Imaizumi T., Matsuda T., Ihle J.N., Yoshimura A. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18:1999;1309-1320
45. Yoshikawa H., Matsubara K., Qian G.S., Jackson P., Groopman J.D., Manning J.E., Harris C.C., Herman J.G. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 28:2001;29-35
46. Zhang J.G., Farley A., Nicholson S.E., Willson T.A., Zugaro L.M., Simpson R.J., Moritz R.L., Cary D., Richardson R., Hausmann G., et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. USA. 96:1999;2071-2076
47. Zhang J.G., Metcalf D., Rakar S., Asimakis M., Greenhalgh C.J., Willson T.A., Starr R., Nicholson S.E., Carter W., Alexander W.S., et al. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo. Proc. Natl. Acad. Sci. USA. 98:2001;13261-13265